scholarly journals Assessment of Patient Satisfaction with Treatments for Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Author(s):  
Huanhuan Lu ◽  
Yiming Ma ◽  
Huihui Zeng ◽  
Yuqin Zeng ◽  
Ping Chen ◽  
...  

Abstract Purpose: Patient satisfaction with treatment is associated with adherence to therapy. This study aimed to investigate the treatment satisfaction level of patients with chronic obstructive pulmonary disease (COPD) and to explore the underlying factors associated with patient satisfaction. Methods: A cross-sectional study was conducted in ambulatory patients at the Second Xiangya Hospital, Changsha, Hunan, between August 1, 2020, and May 31, 2021. The Treatment Satisfaction Questionnaire for Medication version II (TSQM v. II) was used to assess the treatment satisfaction of patients. Multivariable regression analysis was used to determine the factors associated with treatment satisfaction. Results: 392 ambulatory patients with COPD first participated in the study, and 354 patients with are finally available. Median (IQR) score in effectiveness was 66.67(50.00, 66.67), in side effects was 100(100,100), in convenience was 66.67(66.67, 66.67), in global satisfaction was 66.67(50.00, 66.67).Compared with the unsatisfied group, the patients who were satisfied with the treatment had fewer acute exacerbations in the past year (0 vs 1,p<0.001), lower CAT scores(10 vs 13, p<0.001), lower CCQ scores(1.95 vs 2.24, p<0.001), lower GOLD group classification(p<0.001) and lower BODE index[3.00(1.00, 4.25) vs 3.00(2.00, 5.00), p=0.006]. Results indicate that different bronchodilator treatment didn't impact the satisfaction with treatment. The multivariable regression analysis showed that global satisfaction was associated positively with mMRC(β=2.814, p=0.027),while inversely with BMI(β=-0.542, p=0.014), FEV1%predicted(β=-0.135,P=0.024), CAT score(β=-0.342,p=0.033), BODE index(β=-2.057,p=0.023). Conclusion: The results of this study showed that the patients’ satisfaction with treatments is not high in COPD. Different bronchodilator treatment didn't impact the satisfaction with treatment. Keywords: chronic obstructive pulmonary disease, treatment satisfaction, TSQM v. II, bronchodilator

2021 ◽  
Vol 15 (9) ◽  
pp. 2989-2994
Author(s):  
U. Sivakumar ◽  
Rinku Garg ◽  
Sunita Nighute

Objective: COPD has been recognized not only as a lung but also a systemic disease. Smoking is a major cause of COPD, cardiovascular disease, stroke and peripheral arterial disease (PAD). Methods: This was a cross-sectional study conducted at the Department of Physiology, Santosh Medical College diagnosed with COPD using Spirometry was recruited for the study with a sample size of 130 patients. Results: Of the 130 participants, the mean age was 51.73 years of all COPD patients. Thirty-seven (28.46%) were diagnosed to have PAD. Twenty-five patients (19.23%) were overweight, 10 (7.69%) were obese. All the patients included in the study had history of smoking, including current (n= 67, 51.5%) and former (n= 35, 26.9%) smokers. There was no patient with severe respiratory failure in our study. The most common cardiovascular co-morbidity was hypertension (n= 67, 51.5%), followed by diabetes mellitus (n =28, 21.5%), and dyslipidaemia (n= 35, 26.92%). PAD seen in different stages of COPD stage I –IV were 2.94%, 55.88%, 61.76%, 20.58% respectively. Conclusion: The diagnosis of peripheral arterial disease in COPD is important because this is an entity that limits the patient’s physical activity and impairs their quality of life. Lung function was not associated with PAD in patients with COPD. Abnormal ABI results were associated with a higher prevalence of risk factors and more severe lung disease. Keywords: Peripheral Arterial Disease, Smoking, Chronic Obstructive Pulmonary Disease.


2017 ◽  
Vol 5 (1) ◽  
pp. 11-17 ◽  
Author(s):  
Diksha Sapkota ◽  
Yogesh Raj Amatya

Background: Inhalation mode of drug delivery is the mainstay treatment for chronic obstructive pulmonary disease, however; incorrect technique prevents patients from receiving maximal therapeutic benefi ts.Objectives: To assess usage technique of rotahaler among patients with chronic obstructive pulmonary disease and identify factors affecting its performance.Methods: Descriptive cross sectional study was conducted to assess rotahaler (single unit dose dry powder inhaler) inhalation technique among patients with chronic obstructive pulmonary disease in Kathmandu University Teaching Hospital. The study population consisted of 100 respondents using rotahaler for at least one year. Data collection was done by standard checklist, semi structured questionnaire via observation and interview methods respectively.Results: Correct inhalation technique was found in 37% of total respondents. Nearly two out of three respondents (61%) failed to breathe out deeply before inhaling. Majority of the respondents (59%) failed to hold breath for at least 10 second and 25% were unable to breathe in deeply. Age, occupation, source of inhalation instruction and re-demonstration of the technique were found to be signifi cantly associated with the correct inhalation technique (p <0.05).Conclusion: More than half of the respondents had incorrect inhalation technique, so health education program targeting the common identifi ed errors should be carried out. Arrangements should be made for regular involvement of pharmacist in teaching and re-demonstration to ensure good inhaler technique. This would ultimately lead to a greater clinical response and improved patient compliance.Journal of Kathmandu Medical CollegeVol. 5, No. 1, Issue 15, Jan.-Mar., 2016, Page: 11-17


Sign in / Sign up

Export Citation Format

Share Document